DocDollars

Depuy Synthes Products, Inc.

MA · United States · Reporting entity ID 100000005601

Total reported 2019–2025
$620.7M
#31 of 2,960 reporting companies — 0.7% of all reported industry payments
$618.5M in general payments across 15,673 records, plus $2.19M in research funding across 245 records.

How it breaks down

General payments $618,517,089
Research funding $2,187,214

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Depuy Synthes Products, Inc. reported $620.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #31 of 2,960 reporting companies. 0% of that was research funding and 100% general payments such as consulting, speaking, food and travel. 15,673 general payment records and 245 research records were filed.

Common questions about Depuy Synthes Products, Inc.

How much has Depuy Synthes Products, Inc. paid US doctors?

Depuy Synthes Products, Inc. reported $620,704,303 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $618,517,089 in general payments, $2,187,214 in research funding.

How does Depuy Synthes Products, Inc. rank among drug and device companies?

It ranks #31 of 2,960 reporting entities by total reported value, about 0.7% of all industry payments in the dataset.

Does a payment from Depuy Synthes Products, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.